Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

Abstract

The use of gene silencing techniques in the treatment of post-transplantation host rejection is not long lasting and can have systemic effects. Here, the authors utilize a nanocarrier for siRNA for treatment of arteries ex vivo prior to implantation subsequently attenuating immune reaction in vivo.